At a glance
- Originator Fresenius Kabi
- Class Antiemetics; Isoquinolines; Quinuclidines; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
Most Recent Events
- 12 Apr 2018 Launched for Chemotherapy induced nausea and vomiting in USA (Injection)
- 12 Apr 2018 Launched for Postoperative nausea and vomiting in USA (Injection)
- 24 Nov 2017 Chemical structure information added